期刊论文详细信息
PLoS Pathogens
An APE1 inhibitor reveals critical roles of the redox function of APE1 in KSHV replication and pathogenic phenotypes
Yan Yuan1  Canrong Zhong2  Jun Xu2  Mengyang Xu3  Yan Wang4 
[1] Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, Guangdong, China;Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China;Key Laboratory of Tropical Disease Control, Ministry of Education, Sun Yat-Sen University, Guangzhou, Guangdong, China;Research Center for Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, Guangdong, China
关键词: Oxidation-reduction reactions;    Angiogenesis;    DNA replication;    Viral replication;    Virions;    Cytokines;    Kaposi's sarcoma-associated herpesvirus;    Transcription factors;   
DOI  :  10.1371/journal.ppat.1006289
学科分类:生物科学(综合)
来源: Public Library of Science
PDF
【 摘 要 】

APE1 is a multifunctional protein with a DNA base excision repair function in its C-terminal domain and a redox activity in its N-terminal domain. The redox function of APE1 converts certain transcription factors from inactive oxidized to active reduced forms. Given that among the APE1-regulated transcription factors many are critical for KSHV replication and pathogenesis, we investigated whether inhibition of APE1 redox function blocks KSHV replication and Kaposi’s sarcoma (KS) phenotypes. With an shRNA-mediated silencing approach and a known APE-1 redox inhibitor, we demonstrated that APE1 redox function is indeed required for KSHV replication as well as KSHV-induced angiogenesis, validating APE1 as a therapeutic target for KSHV-associated diseases. A ligand-based virtual screening yielded a small molecular compound, C10, which is proven to bind to APE1. C10 exhibits low cytotoxicity but efficiently inhibits KSHV lytic replication (EC50 of 0.16 μM and selective index of 165) and KSHV-mediated pathogenic phenotypes including cytokine production, angiogenesis and cell invasion, demonstrating its potential to become an effective drug for treatment of KS.

【 授权许可】

CC BY   

【 预 览 】
附件列表
Files Size Format View
RO201902018349696ZK.pdf 3958KB PDF download
  文献评价指标  
  下载次数:12次 浏览次数:15次